Increased risk of central venous catheter-associated thrombosis in acute promyelocytic leukemia: A single-institution experience

European Journal of Haematology

Volumn 90, Issue 5, 2013, Pages 397-403

  Grisariu, Sigal ^a   Spectre, Galia ^a   Kalish, Yosef ^a   Gatt, Moshe E ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Acute leukemia; Acute promyelocytic leukemia; Central venous catheter; Thrombosis

Indexed keywords

LOW MOLECULAR WEIGHT HEPARIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CANCER CHEMOTHERAPY; CATHETER THROMBOSIS; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETER ASSOCIATED THROMBOSIS; COMPARATIVE STUDY; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PREVALENCE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; RISK ASSESSMENT; THROMBOCYTE COUNT; THROMBOSIS PREVENTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; INCIDENCE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PLATELET COUNT; RETROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS; UPPER EXTREMITY DEEP VEIN THROMBOSIS; YOUNG ADULT;

EID: 84876734536     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/ejh.12087     Document Type: Article

References (30)

1. Akl EA, Karmath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook D, Schünemann HJ. Anticoagulation for thrombosis prophylaxis in cancer patients with central venous catheters. Cochrane Database Syst Rev 2007;3:CD006468.
2. Boersma RS, Jie KS, Verbon A, van Pampus EC, Schouten HC. Thrombotic and infectious complications of central venous catheters in patients with hematological malignancies. Ann Oncol 2008;19:433-42.
3. De Stefano V, Sora F, Rossi E, Chiusolo P, Laurenti L, Fianchi L, Zini G, Pagano L, Sica S, Leone G. The risk of thrombosis in patients with acute leukemia: occurrence of thrombosis at diagnosis and during treatment. J Thromb Haemost 2005;3:1985-92.
4. Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 2009;27:4858-64.
5. Verso M, Agnelli G. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients. J Clin Oncol 2003;21:3665-75.
6. Caruso V, Iacoviello L, Di Castelnuovo A, Storti S, Donati MB. Venous thrombotic complications in adults undergoing induction treatment for acute lymphoblastic leukemia: results from a meta-analysis. J Thromb Haemost 2007;5:621-3.
7. Mohren M, Markmann I, Jentsch-Ullrich K, Koenigsmann M, Lutze G, Franke A. Increased risk of venous thromboembolism in patients with acute leukaemia. Br J Cancer 2006;94:200-2.
8. Sanz MA, Grimwade D, Tallman MS, et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009;113:1875-91.
9. Tallman MS, Brenner B, Serna JdeL, Dombret H, Falanga A, Kwaan HC, Liebman H, Raffoux E, Rickles FR. Meeting report. Acute promyelocytic leukemia-associated coagulopathy, 21 January 2004, London, United Kingdom. Leuk Res 2005;29:347-51.
10. Falanga A, Marchetti M, Barbui T. All-trans-retinoic acid and bleeding/thrombosis. Pathophysiol Haemost Thromb 2003;33(Suppl 1):19-21.
11. Stein E, McMahon B, Kwaan H, Altman JK, Frankfurt O, Tallman MS. The coagulopathy of acute promyelocytic leukaemia revisited. Best Pract Res Clin Haematol 2009;22:153-63.
12. Hoshal VL Jr. Total intravenous nutrition with peripherally inserted silicone elastomer central venous catheters. Arch Surg 1975;110:644-6.
13. Bottino J, McCredie KB, Groschel DH, Lawson M. Long-term intravenous therapy with peripherally inserted silicone elastomer central venous catheters in patients with malignant diseases. Cancer 1979;43:1937-43.
14. Debourdeau P, Kassab Chahmi D, Le Gal G, et al. 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol 2009;20:1459-71.
15. Strahilevitz J, Lossos IS, Verstandig A, Sasson T, Kori Y, Gillis S. Vascular access via peripherally inserted central venous catheters (PICCs): experience in 40 patients with acute myeloid leukemia at a single institute. Leuk Lymphoma 2001;40:365-71.
16. Prandoni P. Prophylaxis of catheter-related thrombosis in cancer patients. Lancet 2009;373:523-4.
17. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(Suppl 6):381S-453S.
18. Ku GH, White RH, Chew HK, Harvey DJ, Zhou H, Wun T. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood 2009;113:3911-7.
19. Gokbuget N, Raff R, Brugge-Mann M, Flohr T, Scheuring U, Pfeifer H, Bartram CR, Kneba M, Hoelzer D. Risk/MRD adapted GMALL trials in adult ALL. Ann Hematol 2004;83(Suppl 1):S129-31.
20. Steinherz PG, Redner A, Steinherz L, Meyers P, Tan C, Heller G. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol. Cancer 1993;72:3120-30.
21. Rogers JE, Yang D. Differentiation syndrome in patients with acute promyelocytic leukemia. J Oncol Pharm Pract 2012;18:109-14.
22. Melillo L, Grandone E, Colaizzo D, Cappucci F, Valvano MR, Cascavilla N. Symptomatic venous thromboembolism and thrombophilic status in adult acute leukemia: a single-center experience of 114 patients at diagnosis. Acta Haematol 2007;117:215-20.
23. Ziegler S, Sperr WR, Knobl P, Lehr S, Weltermann A, Jager U, Valent P, Lechner K. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. Thromb Res 2005;115:59-64.
24. ®) catheters versus peripherally inserted central catheters in patients with acute myeloid leukemia undergoing induction chemotherapy. Leuk Lymphoma 2012 (Epub ahead of print). ISSN:1042-8194.
25. Breccia M, Avvisati G, Latagliata R, et al. Occurrence of thrombotic events in acute promyelocytic leukemia correlates with consistent immunophenotypic and molecular features. Leukemia 2007;21:79-83.
26. Escudier SM, Kantarjian HM, Estey EH. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid. Leuk Lymphoma 1996;20:435-9.
27. Kinjo K, Miyakawa Y, Uchida H, Kitajima S, Ikeda Y, Kizaki M. All-trans retinoic acid directly up-regulates thrombopoietin transcription in human bone marrow stromal cells. Exp Hematol 2004;32:45-51.
28. Losada R, Espinosa E, Hernandez C, Dorticos E, Hernandez P. Thrombocytosis in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment. Br J Haematol 1996;95:704-5.
29. van Rooden CJ, Schippers EF, Barge RM, Rosendaal FR, Guiot HF, van der Meer FJ, Meinders AE, Huisman MV. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005;23:2655-60.
30. Rees D, Grimwade D, Langabeer S, Burnett A, Goldstone A. Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party. Br J Haematol 1997;96:490-2.